The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Large Volume Wearable Injectors-Global Market Insights and Sales Trends 2025
Synopsis
Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
The global Large Volume Wearable Injectors market size is expected to reach US$ 11290 million by 2029, growing at a CAGR of 33.4% from 2023 to 2029. The market is mainly driven by the significant applications of Large Volume Wearable Injectors in various end use industries. The expanding demands from the Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment and Others, are propelling Large Volume Wearable Injectors market. Electronical Injectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mechanical Injectors segment is estimated at % CAGR for the next seven-year period.
The major players in global Large Volume Wearable Injectors market include Unilife Corporation, BD Medical, etc. The top 2 players occupy about 45% shares of the global market. North America is the main market, and occupies about 70% of the global market. Electronical Injectors is the main type, with a share about 70%. Auto-immune Treatment is the main application, which holds a share about 40%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Large Volume Wearable Injectors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Large Volume Wearable Injectors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Large Volume Wearable Injectors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Large Volume Wearable Injectors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Large Volume Wearable Injectors covered in this report include West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical AG, BD Medical, Enable Injections, Roche Laboratories, scPharmaceuticals and SteadyMed Therapeutics, etc.
The global Large Volume Wearable Injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson
Global Large Volume Wearable Injectors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Large Volume Wearable Injectors market, Segment by Type:
Electronical Injectors
Mechanical Injectors
Others
Global Large Volume Wearable Injectors market, by Application
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Large Volume Wearable Injectors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Large Volume Wearable Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
The global Large Volume Wearable Injectors market size is expected to reach US$ 11290 million by 2029, growing at a CAGR of 33.4% from 2023 to 2029. The market is mainly driven by the significant applications of Large Volume Wearable Injectors in various end use industries. The expanding demands from the Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment and Others, are propelling Large Volume Wearable Injectors market. Electronical Injectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mechanical Injectors segment is estimated at % CAGR for the next seven-year period.
The major players in global Large Volume Wearable Injectors market include Unilife Corporation, BD Medical, etc. The top 2 players occupy about 45% shares of the global market. North America is the main market, and occupies about 70% of the global market. Electronical Injectors is the main type, with a share about 70%. Auto-immune Treatment is the main application, which holds a share about 40%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Large Volume Wearable Injectors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Large Volume Wearable Injectors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Large Volume Wearable Injectors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Large Volume Wearable Injectors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Large Volume Wearable Injectors covered in this report include West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical AG, BD Medical, Enable Injections, Roche Laboratories, scPharmaceuticals and SteadyMed Therapeutics, etc.
The global Large Volume Wearable Injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson
Global Large Volume Wearable Injectors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Large Volume Wearable Injectors market, Segment by Type:
Electronical Injectors
Mechanical Injectors
Others
Global Large Volume Wearable Injectors market, by Application
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Large Volume Wearable Injectors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Large Volume Wearable Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Large Volume Wearable Injectors Market Overview
1.1 Large Volume Wearable Injectors Product Overview
1.2 Large Volume Wearable Injectors Market Segment by Type
1.2.1 Electronical Injectors
1.2.2 Mechanical Injectors
1.2.3 Others
1.3 Global Large Volume Wearable Injectors Market Size by Type
1.3.1 Global Large Volume Wearable Injectors Market Size Overview by Type (2018-2029)
1.3.2 Global Large Volume Wearable Injectors Historic Market Size Review by Type (2018-2023)
1.3.3 Global Large Volume Wearable Injectors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Large Volume Wearable Injectors Sales Breakdown by Type (2018-2023)
1.4.2 Europe Large Volume Wearable Injectors Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Large Volume Wearable Injectors Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Large Volume Wearable Injectors Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Large Volume Wearable Injectors Sales Breakdown by Type (2018-2023)
2 Global Large Volume Wearable Injectors Market Competition by Company
2.1 Global Top Players by Large Volume Wearable Injectors Sales (2018-2023)
2.2 Global Top Players by Large Volume Wearable Injectors Revenue (2018-2023)
2.3 Global Top Players by Large Volume Wearable Injectors Price (2018-2023)
2.4 Global Top Manufacturers Large Volume Wearable Injectors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Large Volume Wearable Injectors Market Competitive Situation and Trends
2.5.1 Large Volume Wearable Injectors Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Large Volume Wearable Injectors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Large Volume Wearable Injectors as of 2022)
2.7 Date of Key Manufacturers Enter into Large Volume Wearable Injectors Market
2.8 Key Manufacturers Large Volume Wearable Injectors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Large Volume Wearable Injectors Status and Outlook by Region
3.1 Global Large Volume Wearable Injectors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Large Volume Wearable Injectors Historic Market Size by Region
3.2.1 Global Large Volume Wearable Injectors Sales in Volume by Region (2018-2023)
3.2.2 Global Large Volume Wearable Injectors Sales in Value by Region (2018-2023)
3.2.3 Global Large Volume Wearable Injectors Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Large Volume Wearable Injectors Forecasted Market Size by Region
3.3.1 Global Large Volume Wearable Injectors Sales in Volume by Region (2024-2029)
3.3.2 Global Large Volume Wearable Injectors Sales in Value by Region (2024-2029)
3.3.3 Global Large Volume Wearable Injectors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Large Volume Wearable Injectors by Application
4.1 Large Volume Wearable Injectors Market Segment by Application
4.1.1 Cancer Treatment
4.1.2 Auto-immune Treatment
4.1.3 Blood Disorders Treatment
4.1.4 Others
4.2 Global Large Volume Wearable Injectors Market Size by Application
4.2.1 Global Large Volume Wearable Injectors Market Size Overview by Application (2018-2029)
4.2.2 Global Large Volume Wearable Injectors Historic Market Size Review by Application (2018-2023)
4.2.3 Global Large Volume Wearable Injectors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Large Volume Wearable Injectors Sales Breakdown by Application (2018-2023)
4.3.2 Europe Large Volume Wearable Injectors Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Large Volume Wearable Injectors Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Large Volume Wearable Injectors Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Large Volume Wearable Injectors Sales Breakdown by Application (2018-2023)
5 North America Large Volume Wearable Injectors by Country
5.1 North America Large Volume Wearable Injectors Historic Market Size by Country
5.1.1 North America Large Volume Wearable Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Large Volume Wearable Injectors Sales in Volume by Country (2018-2023)
5.1.3 North America Large Volume Wearable Injectors Sales in Value by Country (2018-2023)
5.2 North America Large Volume Wearable Injectors Forecasted Market Size by Country
5.2.1 North America Large Volume Wearable Injectors Sales in Volume by Country (2024-2029)
5.2.2 North America Large Volume Wearable Injectors Sales in Value by Country (2024-2029)
6 Europe Large Volume Wearable Injectors by Country
6.1 Europe Large Volume Wearable Injectors Historic Market Size by Country
6.1.1 Europe Large Volume Wearable Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Large Volume Wearable Injectors Sales in Volume by Country (2018-2023)
6.1.3 Europe Large Volume Wearable Injectors Sales in Value by Country (2018-2023)
6.2 Europe Large Volume Wearable Injectors Forecasted Market Size by Country
6.2.1 Europe Large Volume Wearable Injectors Sales in Volume by Country (2024-2029)
6.2.2 Europe Large Volume Wearable Injectors Sales in Value by Country (2024-2029)
7 Asia-Pacific Large Volume Wearable Injectors by Region
7.1 Asia-Pacific Large Volume Wearable Injectors Historic Market Size by Region
7.1.1 Asia-Pacific Large Volume Wearable Injectors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Large Volume Wearable Injectors Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Large Volume Wearable Injectors Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Large Volume Wearable Injectors Forecasted Market Size by Region
7.2.1 Asia-Pacific Large Volume Wearable Injectors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Large Volume Wearable Injectors Sales in Value by Region (2024-2029)
8 Latin America Large Volume Wearable Injectors by Country
8.1 Latin America Large Volume Wearable Injectors Historic Market Size by Country
8.1.1 Latin America Large Volume Wearable Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Large Volume Wearable Injectors Sales in Volume by Country (2018-2023)
8.1.3 Latin America Large Volume Wearable Injectors Sales in Value by Country (2018-2023)
8.2 Latin America Large Volume Wearable Injectors Forecasted Market Size by Country
8.2.1 Latin America Large Volume Wearable Injectors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Large Volume Wearable Injectors Sales in Value by Country (2024-2029)
9 Middle East and Africa Large Volume Wearable Injectors by Country
9.1 Middle East and Africa Large Volume Wearable Injectors Historic Market Size by Country
9.1.1 Middle East and Africa Large Volume Wearable Injectors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Large Volume Wearable Injectors Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Large Volume Wearable Injectors Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Large Volume Wearable Injectors Forecasted Market Size by Country
9.2.1 Middle East and Africa Large Volume Wearable Injectors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Large Volume Wearable Injectors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 West Pharmaceuticals
10.1.1 West Pharmaceuticals Company Information
10.1.2 West Pharmaceuticals Introduction and Business Overview
10.1.3 West Pharmaceuticals Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.1.4 West Pharmaceuticals Large Volume Wearable Injectors Products Offered
10.1.5 West Pharmaceuticals Recent Development
10.2 Unilife Corporation
10.2.1 Unilife Corporation Company Information
10.2.2 Unilife Corporation Introduction and Business Overview
10.2.3 Unilife Corporation Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Unilife Corporation Large Volume Wearable Injectors Products Offered
10.2.5 Unilife Corporation Recent Development
10.3 CeQur
10.3.1 CeQur Company Information
10.3.2 CeQur Introduction and Business Overview
10.3.3 CeQur Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CeQur Large Volume Wearable Injectors Products Offered
10.3.5 CeQur Recent Development
10.4 Sensile Medical AG
10.4.1 Sensile Medical AG Company Information
10.4.2 Sensile Medical AG Introduction and Business Overview
10.4.3 Sensile Medical AG Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sensile Medical AG Large Volume Wearable Injectors Products Offered
10.4.5 Sensile Medical AG Recent Development
10.5 BD Medical
10.5.1 BD Medical Company Information
10.5.2 BD Medical Introduction and Business Overview
10.5.3 BD Medical Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.5.4 BD Medical Large Volume Wearable Injectors Products Offered
10.5.5 BD Medical Recent Development
10.6 Enable Injections
10.6.1 Enable Injections Company Information
10.6.2 Enable Injections Introduction and Business Overview
10.6.3 Enable Injections Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Enable Injections Large Volume Wearable Injectors Products Offered
10.6.5 Enable Injections Recent Development
10.7 Roche Laboratories
10.7.1 Roche Laboratories Company Information
10.7.2 Roche Laboratories Introduction and Business Overview
10.7.3 Roche Laboratories Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Roche Laboratories Large Volume Wearable Injectors Products Offered
10.7.5 Roche Laboratories Recent Development
10.8 scPharmaceuticals
10.8.1 scPharmaceuticals Company Information
10.8.2 scPharmaceuticals Introduction and Business Overview
10.8.3 scPharmaceuticals Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.8.4 scPharmaceuticals Large Volume Wearable Injectors Products Offered
10.8.5 scPharmaceuticals Recent Development
10.9 SteadyMed Therapeutics
10.9.1 SteadyMed Therapeutics Company Information
10.9.2 SteadyMed Therapeutics Introduction and Business Overview
10.9.3 SteadyMed Therapeutics Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.9.4 SteadyMed Therapeutics Large Volume Wearable Injectors Products Offered
10.9.5 SteadyMed Therapeutics Recent Development
10.10 Johnson & Johnson
10.10.1 Johnson & Johnson Company Information
10.10.2 Johnson & Johnson Introduction and Business Overview
10.10.3 Johnson & Johnson Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Johnson & Johnson Large Volume Wearable Injectors Products Offered
10.10.5 Johnson & Johnson Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Large Volume Wearable Injectors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Large Volume Wearable Injectors Industrial Chain Analysis
11.4 Large Volume Wearable Injectors Market Dynamics
11.4.1 Large Volume Wearable Injectors Industry Trends
11.4.2 Large Volume Wearable Injectors Market Drivers
11.4.3 Large Volume Wearable Injectors Market Challenges
11.4.4 Large Volume Wearable Injectors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Large Volume Wearable Injectors Distributors
12.3 Large Volume Wearable Injectors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
